''Developing a Knowledge Base and Infrastructure for Data-Driven and Predictive Drug Development for Alzheimer’s Disease''

Dr Petanceska is a senior advisor for strategic development and partnerships and a program director for systems biology and systems pharmacology in the Division of Neuroscience at the National Institute on Aging (NIA/NIH). During her tenure at the NIA she has been overseeing and developing a number of research portfolios and innovative programs in basic and translational research for Alzheimer’s disease (AD). Her recent program development efforts have been focused on developing systems biology and systems pharmacology capabilities for AD research and drug development within an open science framework. Dr Petanceska was instrumental for the development of NIA’s AD Translational Research Program and leads NIA’s open-science, systems biology programs for target and biomarker discovery: the AMP-AD Target Discovery and Preclinical Validation Project and the M2OVE-AD and Resilience Consortia.